OBI Pharma (4174) — Cash Flow Quality Index

Latest as of June 2023: -1.19x

OBI Pharma (4174) has a Cash Flow Quality Index of -1.19x as of June 2023. Operating cash flow of NT$-401.35 Million is below net income of NT$337.00 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore OBI Pharma long-term investment intensity to see how much of total assets are deployed in long-term investments.

Cash Flow Quality Index

-1.19x

Operating CF / Net Income

Operating Cash Flow

NT$-401.35 Million

TWD

Net Income

NT$337.00 Million

TWD

Data as of

Jun 2023

Most recent filing

Annual Cash Flow Quality Index for OBI Pharma (None–None)

Year-by-year earnings quality comparison for OBI Pharma. For live market cap and the full company financial profile, see OBI Pharma market cap and net worth.

Year	Quality Index	Operating CF (TWD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.